European specialist investor Gilde Healthcare has announced the first and final close of Gilde Healthcare V, a €416m (US$450m) venture and growth capital fund. The new fund, which was oversubscribed, targets growth opportunities in a broad range of healthcare sectors including digital health, medtech and therapeutics both in Europe and North America. Gilde said that…
©2023 All rights reserved LaingBuisson 
 venture and growth capital fund.){kind=link}